Atlas Venture

Atlas Venture is a private equity and venture capital firm based in Cambridge, Massachusetts, founded in 1980. The firm specializes in early-stage investments, particularly in the life sciences and technology sectors, with a strong emphasis on biotechnology and personalized medicine. Atlas Venture adopts a seed-led venture creation strategy, rigorously selecting opportunities to build scalable businesses. It typically invests between $0.25 million and $15 million per transaction, preferring to be a lead investor and to obtain board representation in its portfolio companies. The firm primarily focuses on startups in the United States and Europe, particularly in New England and the San Francisco Bay Area. Since its inception, Atlas Venture has managed over $2 billion in committed capital and has been involved in the creation and growth of numerous companies, with many achieving significant exits through acquisitions or public offerings. The firm has distinct teams dedicated to life sciences and technology investments, allowing for specialized attention in these dynamic fields.

Laura Alessio

Director of Portfolio operations

Peter Barrett

Partner

Kevin Bitterman

Partner

Bruce Booth

Partner

Ommer Chohan

CFO

Philippe Claude

Senior Partner

Micheal Du Cros

Partner

Rajesh Devraj

Venture Partner

Maurizio Fazio Ph.D

Principal

Jean-Francois Formela

Partner

Jernej Godec

Associate

David Grayzel

Managing Director

Chelsea Place Johnson

Principal

Gerard Montanus

Senior Partner

Julia Pian

Associate

Josh Powers

Associate

Aimee Raleigh

Principal

Steven Robinette

Venture Partner

Uciane Scarlett

Associate

Jay Shiveley

Principal

Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.